Risk factors for multidrug-resistant tuberculosis in four centers in burkina faso, West Africa

Microbial Drug Resistance

Volumn 15, Issue 3, 2009, Pages 217-221

  Diandé, Souba ^a,b   Sangaré, Lassana ^b,c,d   Kouanda, Séni ^b   Dingtoumda, Benoît I ^a   Mourfou, Adama ^a   Ouédraogo, Francis ^a   Sawadogo, Issaka ^a   Nébié, Bayéma ^a   Gueye, Abdoulaye ^a   Sawadogo, Léon T ^a   Traoré, Alfred S ^b  

^a National Center Against Tuberculosis   (Burkina Faso)

^b UNIVERSITÉ DE OUAGADOUGOU   (Burkina Faso)

^c University Hospital   (Burkina Faso)

^d University Hospital Yalgado Ouedraogo   (Burkina Faso)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; BURKINA FASO; CASE CONTROL STUDY; CONTROLLED STUDY; FEMALE; GEOGRAPHIC DISTRIBUTION; HUMAN; INFECTION RISK; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; RISK ASSESSMENT;

ADOLESCENT; ADULT; AGED; BURKINA FASO; CASE-CONTROL STUDIES; FEMALE; HUMANS; INTERVIEWS AS TOPIC; MALE; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; RISK ASSESSMENT; RISK FACTORS; TUBERCULOSIS, MULTIDRUG-RESISTANT; TUBERCULOSIS, PULMONARY; YOUNG ADULT;

JOTURUS PICHARDI;

EID: 69949129531     PISSN: 10766294     EISSN: None     Source Type: Journal    
DOI: 10.1089/mdr.2009.0906     Document Type: Article

References (34)

1. Ben Amor, Y., B. Nemser, A. Singh, A. Sankin, and N Schluger. 2008. Underreported threat of multidrug-resistant tuberculosis in Africa. Emerg. Infect. Dis. 14:1345-1348.
2. Braun, M.M., J.O. Kilburn, R.W. Smithwick, I.M. Couli-baly, D. Coulibaly, V.A. Silcox, E. Gnaore, G. Adjorlolo, and K.M. De Cock. 1992. HIV infection and primary resistance to antituberculosis drug in Abidjan, Cote d'Ivoire. AIDS 6:1327-1330.
3. Canetti, G., N. Rist, and J. Grosset. 1963. Mesure de la sensibilité du bacille tuberculeux aux drogues antibacillaires par la méthode des proportions. Rev. Tuberc. Pneumol. 27:217-272. (In French.)
4. Cardoso, E.M. 2004. Multiple drug resistance: a threat for tuberculosis control. Rev. Panam. Salud Publ. 16:68-73.
5. Casal, M., M. Vaquero, H. Rinder, E. Tortoli, J. Grosset, S. Rusch-Gerdes, J. Gutieérrez, and V. Jarlier. 2005. A case-control study for multidrug-resistant tuberculosis risk factors in four European country. Microb. Drug Resist. 11:62-67.
6. Chum, H.J., R.J. O'Brien, T.M. Chonde, P. Graf, and H.L. Rieder. 1996. An epidemiological study of tuberculosis and HIV infection in Tanzania, 1991-1993. AIDS 10:299-309.
7. Edlin, B.R., J.I. Tokars, M.H. Grieco, J.T. Crawford, J. Williams, E.M. Sordillo, K.R. Ong, J.O. Kilburn, S.W. Dooley, and K.G. Castro. 1992. An outbreak of multidrug-resistant tuberculosis among hospitalized patients with the acquired immunodeficiency syndrome. N. Engl. J. Med. 326:1514-1521.
8. Espinal, M.A. 2003. The global situation of MDR-TB. Tuberculosis 83:44-51.
9. Faustini, A., A.J. Hall, and C.A. Perucci. 2006. Risk factors for multidrug resistant tuberculosis in Europe: a systematic review. Thorax 61:158-163.
10. Frieden, T.R., T. Sterling, A. Pablos-Mendez, J.O. Kilburn, G.M. Cauthen, and S.W. Dooley. 1993. The emergence of drug-resistant tuberculosis in New York City. N. Engl. J. Med. 328:521-532.
11. Githui, W., P.P. Nunn, E. Juma, F. Karimi, R. Brindle, R. Kamunyi, S. Gathua, C. Gicheha, J. Morris, and M. Omwega. 1992. Cohort study of HIV-positive and HIV-negative tuberculosis, Nairobi, Kenya: comparison of bacteriological results. Tuberc. Lung Dis. 73:203-209.
12. Helali, El.N., and P. Vergez. 1993. Identification des my-cobactéries. Feuillets de Biologie XXXIV:5-19. (In French)
13. Holmes, C.B., H. Hausler, and P. Nunn. 1998. A review of sex differences in the epidemiology of tuberculosis. Int. J. Tuberc. Lung Dis. 2:96-104.
14. Holtz, T.H., J. Lancaster, K.F. Laserson, C.D. Wells, L. Thorpe, and K. Weyer. 2006. Risk factors associated with default from multidrug-resistant tuberculosis treatment, South Africa, 1999-2001. Int. J. Tuberc. Lung Dis. 10:649-655.
15. Hudelson, P. 1996. Gender differentials in tuberculosis: the role of socio-economic and cultural factors. Int. J. Tuberc. Lung Dis. 77:391-400.
16. Joshua, F. 2006. MDR-TB and HIV: the perfect storm? Am. J. Trop. Med. Hyg. 75:1025-1026.
17. Kenyon, T.A., R. Ridzon, R. Luskin-Hawk, C. Schultz, W.S. Paul, S.E. Valway, I.M. Onorato, and K. Castro. 1997. Nosocomial outbreak of multidrug-resistant tuberculosis. Ann. Intern. Med. 127:32-36.
18. Kuaban, C., S. Koulla-Shiro, and P. Hagbé. 1997. Car-actéristiques des patients adultes morts de tuberculose pulmonaire active à Yaoundé-Cameroun. Méd. Afr. Noire. 44:345-349. (In French.)
19. Ledru, S., B. Cauchoix, M. Yameogo, J. Lamandé-Chiron, F. Portaels, and J.P. Chiron. 1996. Impact of short-course therapy on tuberculosis drug resistance in South-West Burkina Faso. Tuberc. Lung Dis. 77:429-436.
20. Mugusi, F., A.B. Suvai, and K.G. Albertin. 1990. Increased of diabetes mellitus in patients with pulmonary tuberculosis in Tanzania. Tuberculosis 71:271-276.
21. Ormerod, L.P. 2005. Multidrug-resistant tuberculosis (MDR-TB): epidemiology, prevention and treatment. Br. Med. Bull. 73:17-24.
22. Singh, M.M., and K.K. Chopra. 2004. MDR-TB current issues. Indian J. Tuberc. 51:1-3.
23. UNAIDS=WHO. 1997. Revised recommendations for the selection and use of HIV antibody tests. Wkly. Epidemiol. Rec. 72:81-87.
24. Van Lettow, M., A.D. Harries, J.J. Kumwenda, E.E. Zijlstra, T.D. Clark, T.E. Taha, and R.D. Semba. 2004. Links mi-cronutrient malnutrition and wasting in adults with pulmonary tuberculosis with and without HIV co-infection in Malawi. BMC Infect. Dis. 4:61(1-8
25. Van Lettow, M., J.J. Kumwenda, A.D. Harries, C.C. Whalen, T.E. Taha, A.N. Kumwenda, C. Kang'Ombe, and R.D. Semba. 2004. Malnutrition and severity of lung disease in adults with pulmonary tuberculosis in Malawi. Int. J. Tuberc. Lung Dis. 8:211-217.
26. Villamor, E., E. Saathoff, F. Mugusi, C.C. Whalen, T.E. Taha, A.N. Kumwenda, C. Kang'Ombe, R.D. Semba, R.J. Bosch, W. Urassa, and W.W. Fawzi. 2006. Wasting and body composition of adults with pulmonary tuberculosis in relation to HIV-1 coinfection, socioeconomic status, and severity of tuberculosis. Eur. J. Clin. Nutr. 60:163-171.
27. Warndorff, D.K., M. Yates, B. Ngwira, S. Chagaluka, P.A. Jenkins, F. Drobniewski, J.M. Pönnighaus, J.R. Glynn, and P.E.M. Fine. 2000. Trends in antituberculosis drug resistance in Karonga, Malawi, 1986-1998. Int. J. Tuberc. Lung Dis. 4: 752-757.
28. Wells, D.C., J. Peter Cegielski, L.J. Nelson, K.F. Laserson, T.H. Holtz, A.F. Kenneth, and K. Weyer. 2007. HIV infection and multidrug-resistant tuberculosis-the perfect storm. J. Infect. Dis. 196 Suppl 1: S86-S88.
29. Weyer, K., J. Brand, J. Lancaster, J. Levin, and M. van der Walt. 2007. Determinants of multidrug-resistant tuberculosis in South Africa: results from a national survey. S. Afr. Med. J. 97:1120-1128.
30. Wilkinson, D., M. Pillay, G.R. Davies, and A.W. Sturm. 1996. Resistance to antituberculosis drugs in rural South Africa: rates, patterns, risk and transmission dynamics. Trans. R. Soc. Trop. Med. Hyg. 90:692-695.
31. World Health Organization. 2008. Anti-Tuberculosis Resistance in the World. Report no4. The WHO=IUATLD Global Project on Anti-Tuberculosis Drug Resistance Surveillance 2002-2007. WHO=HTM=TB=2008.394. Geneva, pp. 1-142.
32. World Health Organization. 2006. Guidelines for the Programmatic Management of Drug-Resistant Tuberculosis. WHO=HTM=TB=2006.361. Geneva, pp. 1-186.
33. World Health Organization. 2004. Anti-Tuberculosis Drug Resistance in the World. Report No3. The Global Project on Anti-Tuberculosis Drug Resistance Surveillance 1999-2002. WHO=HTM=TB=2004.343. Geneva, pp. 1-129.
34. Zignol, M., M.S. Hosseini, A. Wright, C.L. van Weezenbeek, P. Nunn, C.J. Watt, B.G. Williams, and C. Dye. 2006. Global incidence of multidrug-resistant tuberculosis. J. Infect. Dis. 194:479-485.